.
All cells were grown as monolayers on plastic in 25cm2 flasks (Nunc; Gibco, Paisley, Scotland) and used over a restricted culture period of 10 passages. The cells were maintained in RPMI medium Drug sensitivities in vitro were measured using a clonogenic assay methology, as described previously were washed using three batches of supplemented medium, once with PBSA and then detached using a mixture of 0.1% trypsin (Difco 1:250, London, England) and 0.003% EDTA (BDH Chemicals Poole, England) in PBSA. The cells were diluted in supplemented medium and plated in 5cm plastic petri dishes (Nunc) containing 5 ml of supplemented medium at cell densities calculated to yield approximately 100-200 colonies per dish. Plating efficiency was constant over the range of cell densities used for all of these lines. The cells were incubated under standard conditions for 8-21 days, depending on the growth rate of the cell line. For incubations of 14 days or longer the medium was replaced at 7 day intervals. The colonies were fixed .0 C 0) 0 .)_ in methanol (BDH) and stained with 10% Giemsa (Gurr's improved R66; BDH) and those consisting of 50 or more cells scored by observation under a binocular dissecting microscope. The mean colonyforming ability of drug-treated cells was expressed as a percentage of that of control cells. A minimum of three experiments was completed for each drug and every cell line.
The dose-response curves of the 8 distinct cell lines following 24 h exposure to adriamycin and methotrexate are shown in Figures 1 and 2 , respectively. In response to adriamycin, all but one cell line showed an exponential dose-response with a short initial shoulder region. The exception, 253J, exhibited a biphasic curve, proving relatively resistant at high drug concentrations. With methotrexate all but one cell line had dose responses which were initially exponential and then plateaued at high drug concentrations. The one exception, HT1376, was extremely resistant and exhibited a shallow dose-response. The four crosscontaminated sublines were not included in these figures, since their dose-response curves were not significantly different from that of their parent line, T24.
The concentration of each drug required to reduce clonogenic cell survival by 70% (ID70) and the percentage survival at one concentration of each drug for the 12 cell lines are listed in Table II . The rank order of sensitivities amongst the cell lines differed markedly between the two drugs, although T24 was the most sensitive line to both agents. The shapes of the dose-response curves were identical to those previously described for these agents in vitro (Hill, 1978 because cell lines can be derived from only a minority of bladder tumours, and most patients with advanced bladder cancer usually receive combination chemotherapy, not single agents, often some years after the primary tumour has been resected. However, there are at least three lines of indirect evidence indicating that the in vitro sensitivities of cell lines reflect the clinical response of the tumours of origin. Firstly, a comparison of human lung cancer cell lines from untreated patients and from those who had relapsed following combination chemotherapy indicated that the untreated tumours were all more sensitive than the resistant tumours (Carney et al., 1983) . Secondly, the in vitro sensitivities of human melanoma xenografts correlated strongly with in vivo response, except in two cases in which the derived cell lines also lost the capacity to produce tumours on transplantation (Tveit et al., 1981) . Thirdly, we have shown that cell lines derived from a tumour type curable by chemotherapy, testicular germ cell tumours, are on average five times more sensitive to adriamycin and cis-platin than bladder cell lines (Walker et al., 1985) . Cumulatively these studies suggest that, following careful characterization, cell lines that reflect the drug sensitivities of their tumour of origin can be selected. If cell lines are to be used for preclinical drug screening, it is necessary also that in vitro drug sensitivities remain relatively stable in long-term culture. In this study we compared the in vitro chemosensitivities of T24 and four sublines, which had been cultured in different laboratories separately for periods of up to 10 years. All the lines had similar sensitivities to both methotrexate and adriamycin, indicating that drug response can be stable in long-term culture. In support of this finding no differences in drug sensitivities were observed between early and permanent cultures derived from human melanoma xenografts (Tveit et al., 1981) . Similarly, no significant change in 6-mercaptopurine sensitivity has been observed in the KB (Hela) cell line over a period of 22 years, based on data from over 2,000 assays in 13 laboratories (Shoemaker et al., 1983) . In addition, two human breast cell lines derived from the same biopsy exhibited similar cell survival curves following exposure to X-irradation and 12 chemotherapeutic drugs (Gioanni et al., 1985) . However, in contrast to these data, there are many reports (reviewed by Heppner, 1984) 
